Navigation Links
Breast cancer risk drops when diet includes walnuts, Marshall researchers find
Date:9/1/2011

The risk of breast cancer dropped significantly in mice when their regular diet included a modest amount of walnut, Marshall University researchers report in the journal Nutrition and Cancer.

The study, led by Elaine Hardman, Ph.D., of Marshall's Joan C. Edwards School of Medicine, compared the effects of a typical diet and a diet containing walnuts across the lifespan: through the mother from conception through weaning, and then through eating the food directly. The amount of walnut in the test diet equates to about 2 ounces a day for humans.

Hardman said that during the study period, the group whose diet included walnut at both stages developed breast cancer at less than half the rate of the group with the typical diet. In addition, the number of tumors and their sizes were significantly smaller.

"These reductions are particularly important when you consider that the mice were genetically programmed to develop cancer at a high rate," Hardman said. "We were able to reduce the risk for cancer even in the presence of a preexisting genetic mutation."

The paper notes that dietary modification studies do not show whether benefits result from what is added to a diet or what is removed.

In this case, adding healthy fat and other components meant that unhealthy fat was reduced to keep total dietary fat balanced in the mice.

Hardman said other studies have clearly shown, however, that multiple ingredients in walnuts reduce the risk of cancer or slow its growth.

Using genetic analysis, the Marshall study found that the walnut-containing diet changed the activity of multiple genes that are relevant to breast cancer in both mice and humans. Other testing showed that increases in omega 3 fatty acids did not fully account for the anti-cancer effect, and found that tumor growth decreased when dietary vitamin E increased.

Hardman said the findings highlight the vital role diet plays in health.<
'/>"/>

Contact: Beverly McCoy
mccoy@marshall.edu
304-691-1713
Marshall University Research Corporation
Source:Eurekalert  

Page: 1 2

Related biology news :

1. UH researchers explore treatments for breast and colon cancers
2. Malignant stem cells may explain why some breast cancers develop and recur
3. Higher estrogen production in the breast could confer greater cancer risk than thought
4. Using a systems biology approach to look under the hood of an aggressive form of breast cancer
5. Key metabolic pathway implicated in intractable form of breast cancer
6. Trastuzumab and chemotherapy improved survival in HER2-postive breast and brain cancer patients
7. PSA test for men could get a second life for breast cancer in women
8. Team identifies new breast cancer tumor suppressor and how it works
9. New clinical trial to test novel approach to treat triple-negative breast cancer
10. Scientists find new drug target in breast cancer
11. Cancer scientists discover new way breast cancer cells adapt to environmental stress
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breast cancer risk drops when diet includes walnuts, Marshall researchers find
(Date:4/1/2015)... 1, 2015   Medisafe ™, the leading global ... iOS and Android smartphones and ... into the platform to allow patients to track and ... first time, patients will be able to visualize in ... important biometrics, such as glucose levels and blood pressure. ...
(Date:3/31/2015)... , March 31, 2015   Guidepoint , ... launch of the Post-Surgical Pain Management TRACKER, part of ... tracking usage trends in the medical device and therapeutics ... to data including treatment volumes, market share, and adoption ... pain associated with joint surgery. The Post-Surgical ...
(Date:3/26/2015)... , March 26, 2015 The ... social, recreation and athletic club, today announced it has ... allow freedom of movement for members and staff, while ... a comprehensive process, we selected FST,s IMID Access system ... convenience for our members and staff, in addition to ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... vulnerable to their environment during embryonic development than females, ... University of Glasgow in the UK. Until now, the ... conditions during the embryonic stage in birds have received ... in Springers journal, Behavioral Ecology and Sociobiology. In ...
... of PocketCop Software, WALL, N.J., May 6 ... leader in finger-based biometric,identification and wireless public safety ... latest mobile data solution for BlackBerry(R),smartphones at the ... be held May 7-9 at the Gaylord Opryland ...
... brand now includes hi-tech gun and storage chest, ... BMRX), today announced that it has added two new ... which are,immediately available at retailers and online specialty sites., ... products as we grow our,smartTOUCH product line of consumer ...
Cached Biology News:Seagulls: Are males the weaker sex? 2BIO-key(R) Showcasing Public Safety Solutions for BlackBerry Smartphones at 2008 LEIM Conference 2BIO-key(R) Showcasing Public Safety Solutions for BlackBerry Smartphones at 2008 LEIM Conference 3bioMETRX, Inc. Introduces New Products 2
(Date:4/21/2015)... April 21, 2015 YourEncore, an ... life sciences, consumer products and food sciences industries ... the Alliance for Clinical Research Excellence and Safety ... for conducting clinical research, have partnered to speed ... , YourEncore brings to ACRES experts with ...
(Date:4/20/2015)... MENLO PARK, Calif. , April ... (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical ... therapies in new orphan drug indications, today announced ... Meeting of the American Association for Cancer Research ... its lead product candidate VAL-083 (dianhydrogalactitol) ...
(Date:4/20/2015)... , April 20, 2015 ... for healing bone injuries. The orthobiologics market is a ... for its stakeholders. The global orthobiologics market report defines ... of revenue. The global orthobiologics market was valued at ... $7,900.2 million by 2019, at a CAGR of 6.7% ...
(Date:4/20/2015)... 20, 2015 PointCross Life Sciences today announced ... an integrated Big Data and globally accessible environment for ... the context of clinical trials and nonclinical studies. This ... drug candidates, stratified patient selection and ex post ... Highlighting the timing of this partnership, ...
Breaking Biology Technology:YourEncore and ACRES Partner to Drive Innovation in Clinical Research 2YourEncore and ACRES Partner to Drive Innovation in Clinical Research 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 2DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 3DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4DelMar Pharmaceuticals Presents Promising Preclinical Data on VAL-083's Potential to Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 5Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 2Global Orthobiologics Market is Expected to Reach $7,900.2 Million by 2019, at a CAGR of 6.7% from 2014 to 2019 3PointCross Life Sciences and InterpretOmics partner for Clinical and Genomic Biomarker Management for Drug Development 2
... TUALATIN, Ore. , Jan. 26 Waytronx, ... to the acquisition, development, and commercialization of new, innovative ... with British-based Ingenion Design Ltd. ("Ingenion") to develop and ... (GasPT2). , The GasPT2, designed by GL Industrial Services ...
... SHANGHAI , Jan. 26 /PRNewswire-Asia/ ... Company in China , announced,that a French delegation led ... January 22, 2010 . M.Raffarin, currently President,of Foundation Prospective ... Mr. Erwan Davoux of the foundation, and Dr. ...
... , , STOCKHOLM ... - part of,the Karolinska Development portfolio - announced today ... to continue its clinical,development program. Based on cardio-protective effects, ... new therapy for treating acute,coronary syndrome (ACS) and reperfusion ...
Cached Biology Technology:Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited 2Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited 3Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited 4Former French Prime Minister Jean-Pierre Raffarin Visits Sundia 2Eribis Pharmaceuticals Receives Investment for Clinical Development of Novel Cardiovascular Therapy 2
... serine/threonine phosphatase isolated from human red blood ... of 60kDa (A) and 36kDa (C) subunits. ... a-subunit of phosphorylase kinase. With its 3638kDa ... and may play a regulatory role in ...
... ATP Monitoring Kit measures adenosine ... sensitivity and a dynamic range. ... the assay measures ATP in ... over a concentration range of ...
... refrigerated cold traps offers a choice of ... solvents or high volatility solvents. Ideal to ... evaporators. Also used for maintaining vapor-free gas ... in electron microscopes. Can be used as ...
96 Well Plate Sterile, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
Biology Products: